Domov › Hodgkinov limfom › Texas
Klinične študije za Hodgkinov limfom v Texas
15 študij za Hodgkinov limfom išče udeležence na lokacijah v Texas.
Mesta v Texas
Uradno besedilo študije (angleško)
Constitutive IL7R (C7R) Modified Banked Allogeneic CD30.CAR EBVSTS for CD30-Positive Lymphomas
- Houston Methodist Hospital, Houston
- Texas Children's Hospital, Houston
Vključevanje udeležencevFaza 1
Starost 12–75 · Vsi spoli · Posodobljeno 2. okt. 2026 · NCT06176690CD30 CAR T Cells, Relapsed CD30 Expressing Lymphoma (RELY-30)
- Houston Methodist Hospital, Houston
- Texas Children's Hospital, Houston
Vključevanje udeležencevFaza 1
Starost 12–75 · Vsi spoli · Posodobljeno 2. okt. 2026 · NCT02917083Pharmacokinetic Study of Venetoclax Tablets Crushed and Dissolved Into a Solution
- Texas Children's Hospital, Houston
Vključevanje udeležencevOpazovalna študija
Starost 0–38 · Vsi spoli · Posodobljeno 1. okt. 2026 · NCT06131801A Phase II Trial of Mosunetuzumab, Polatuzumab, Tafasitamab, and Lenalidomide in Patients With Relapsed B-cell NHL
- M D Anderson Cancer Center, Houston
Vključevanje udeležencevFaza 2
Starost 18 in več · Vsi spoli · Posodobljeno 18. sep. 2026 · NCT05615636Safety and Preliminary Efficacy of MT-601 in Patients With Relapsed/Refractory Lymphoma
- Sarah Cannon Research Institute at St. David's South Austin, Austin
Vključevanje udeležencevFaza 1
Starost 18–100 · Vsi spoli · Posodobljeno 15. sep. 2026 · NCT05798897AZD3470 as Monotherapy or in Combination With Anticancer Agent(s) in Participants With Haematologic Malignancies.
- Research Site, Houston
Vključevanje udeležencevFaza 1/2
Starost 12 in več · Vsi spoli · Posodobljeno 14. sep. 2026 · NCT06137144Phase1 Basket Trial Of CAR.70-Engineered IL15-Transduced With TGFBR2 Knock Out Cord Blood-Derived NK Cells For Relapsed/Refractory Lymphoid Malignancies
- The University of Texas M. D. Anderson Cancer Center, Houston
Vključevanje udeležencevFaza 1
Starost 18–75 · Vsi spoli · Posodobljeno 8. sep. 2026 · NCT07444632Phase II Study Of Nivolumab Plus AVD In Pediatric, Adolescent, And Young Adult Patients With CHL
- UT MD Anderson, Houston
Vključevanje udeležencevFaza 2
Starost 2–21 · Vsi spoli · Posodobljeno 31. avg. 2026 · NCT07551583Phase I/II Study of CAR.70- Engineered IL15-transduced Cord Blood-derived NK Cells in Conjunction With Lymphodepleting Chemotherapy for the Management of Relapse/Refractory Hematological Malignances
- M D Anderson Cancer Center, Houston
Vključevanje udeležencevFaza 1/2
Starost 12–80 · Vsi spoli · Posodobljeno 7. avg. 2026 · NCT05092451Personalized NK Cell Therapy in CBT
- M D Anderson Cancer Center, Houston
Vključevanje udeležencevFaza 2
Starost 15–80 · Vsi spoli · Posodobljeno 30. jul. 2026 · NCT02727803A Multicenter Access and Distribution Protocol for Unlicensed Cryopreserved Cord Blood Units (CBUs)
- Medical City Dallas, Dallas
- Children's Medical Center Dallas, Dallas
- Zachary & Elizabeth Fisher Bone Marrow Transplant Program (Brooke Army Medical Center), Fort Sam Houston
- in še 5
Vključevanje udeležencevOpazovalna študija
Vse starosti · Vsi spoli · Posodobljeno 6. jul. 2026 · NCT01351545EBV Specific T-Lymphocytes for Treatment of EBV-Positive Lymphoma
- Harris Health System - Ben Taub General Hospital/Smith Clinic, Houston
- Houston Methodist Hospital, Houston
- Texas Children's Hospital, Houston
- in še 1
Vključevanje udeležencevFaza 1
Vse starosti · Vsi spoli · Posodobljeno 25. jun. 2026 · NCT04664179A Phase II Study of the Combination of Azacitidine and Pembrolizumab for Patients Relapsed/Refractory Hodgkin's Lymphoma
- MD Anderson Cancer Center, Houston
Vključevanje udeležencevFaza 2Vabljeni zdravi prostovoljci
Starost 1 in več · Vsi spoli · Posodobljeno 18. maj 2026 · NCT05355051Cytotoxic T-Lymphocytes for EBV-positive Lymphoma, GRALE
- Harris Health System (includes ben Taub General Hospital and Smith), Houston
- Houston Methodist Hospital, Houston
- Texas Children's Hospital, Houston
Vključevanje udeležencevFaza 1
Vse starosti · Vsi spoli · Posodobljeno 2. mar. 2026 · NCT01555892Tagraxofusp in Pediatric Patients With Relapsed or Refractory CD123 Expressing Hematologic Malignancies
- University of Texas, Southwestern, Dallas
- Cook Children's Hospital, Fort Worth
- Texas Children's Hospital/Baylor College of Medicine, Houston
Vključevanje udeležencevFaza 1
Starost 1–21 · Vsi spoli · Posodobljeno 6. dec. 2024 · NCT05476770Vir: ClinicalTrials.gov, podatki pridobljeni 5. okt. 2026. Vsaka študija ima svoje pogoje vključitve; ekipa študije odloči, kdo lahko sodeluje.